title: Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics.
authors.forename: Walter
authors.initials: W
authors.lastname: Wolf
authors.forename: Cary A
authors.initials: CA
authors.lastname: Presant
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000097:blood / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000097:blood* / Q000493:pharmacokinetics*; D004347:Drug Interactions; D005472:Fluorouracil / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000737:chemistry* / Q000378:metabolism*; D009944:Organoplatinum Compounds / Q000009:adverse effects; D000077150:Oxaliplatin
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005472:Fluorouracil